Clinical Trials › NCT07225361
RecruitingPhase 4
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Sponsored by Northwestern University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 40
Target enrollment
1
U.S. states
Nov 2025
Start date
Aug 2029
Expected completion
Interventions / Treatments
Ublituximab
Conditions studied
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting
Where this trial is running (1 site)
Illinois1 site
Chicago
Participating MS centers on MS Buddy (1)
MS centers in Illinois
Compare treatment centers near a trial site by center type, providers and trials.
View Illinois centersMore Phase 4 trials
Browse all Phase 4 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.